ID

31306

Descripción

Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin Any adverse experience is defined as a new or worsening pre-existing medical condition or complication occurring while on study, regardless of its perceived relationship to the drug. Please record all adverse experiences from the time of study entry through the Week 13 visit.

Palabras clave

Versiones (1)
  1. 12/8/18 12/8/18 -
Titular de derechos de autor

see clinicaltrials.gov

Subido en

12 de agosto de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755

Inglés

Adverse Experiences

1 formularios  
  1. StudyEvent: ODM
    1. Adverse Experiences
Administrative Data
Descripción

Administrative Data

Alias
UMLS CUI-1
C1320722
Site Number
Descripción

Site number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0018704
UMLS CUI [1,2]
C0600091
Patient Number
Descripción

Patient Number

Tipo de datos

text

Alias
UMLS CUI [1]
C1830427
Patient Initials
Descripción

Patient Initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Adverse Experiences
Descripción

Adverse Experiences

Alias
UMLS CUI-1
C0877248
AE #
Descripción

Adverse Event; Number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0237753
Adverse Experience (one experience per line)
Descripción

Adverse Event

Tipo de datos

text

Alias
UMLS CUI [1]
C0877248
Grade per CTC (per Appx F)
Descripción

Adverse Event; CTC grade

Tipo de datos

text

Alias
UMLS CUI [1]
C2985911
Serious
Descripción

Adverse event, serious

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1519255
Onset Date
Descripción

Adverse event; start date

Tipo de datos

date

Alias
UMLS CUI [1]
C2697888
Stop Date
Descripción

Adverse event; end date

Tipo de datos

date

Alias
UMLS CUI [1]
C2697886
Frequency
Descripción

Adverse event; frequency

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0439603
Therapeutic Measures: Drugs
Descripción

Adverse event; Therapeutic Measures; Drugs

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0013227
Therapeutic Measures: Other
Descripción

Adverse event; Therapeutic Measures; Other

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205394
Therapeutic Measures: If Other, specify here
Descripción

Adverse event; Therapeutic Measures; Other; Specification

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C2348235
Outcome
Descripción

Adverse event; Outcome

Tipo de datos

text

Alias
UMLS CUI [1]
C1705586
Relationship: Drug
Descripción

Adverse event; Relationship; Drug

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0013227
Relationship: Disease
Descripción

Adverse event; Relationship; Disease

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0012634
Volver a la parte superior de la página

Similar models

Adverse Experiences

1 formularios
  1. StudyEvent: ODM
    1. Adverse Experiences
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Site number
Item
Site Number
text
C0018704 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Adverse Experiences
C0877248 (UMLS CUI-1)
Adverse Event; Number
Item
AE #
integer
C0877248 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Adverse Event
Item
Adverse Experience (one experience per line)
text
C0877248 (UMLS CUI [1])
Adverse Event; CTC grade
Item
Grade per CTC (per Appx F)
text
C2985911 (UMLS CUI [1])
Adverse event, serious
Item
Serious
boolean
C1519255 (UMLS CUI [1])
Adverse event; start date
Item
Onset Date
date
C2697888 (UMLS CUI [1])
Adverse event; end date
Item
Stop Date
date
C2697886 (UMLS CUI [1])
Adverse event; frequency
Item
Frequency
text
C0877248 (UMLS CUI [1,1])
C0439603 (UMLS CUI [1,2])
Adverse event; Therapeutic Measures; Drugs
Item
Therapeutic Measures: Drugs
text
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Adverse event; Therapeutic Measures; Other
Item
Therapeutic Measures: Other
text
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Adverse event; Therapeutic Measures; Other; Specification
Item
Therapeutic Measures: If Other, specify here
text
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
Adverse event; Outcome
Item
Outcome
text
C1705586 (UMLS CUI [1])
Adverse event; Relationship; Drug
Item
Relationship: Drug
text
C0877248 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Adverse event; Relationship; Disease
Item
Relationship: Disease
text
C0877248 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial